It has become more evident, that long term cigarette smoking (LTCS) has an important 27 extrapulmonary toxicity. The aim of the study was to investigate the time dependent effects 28 of cigarette smoke exposure on exercise capacity, markers of systemic inflammation and 29 skeletal muscle structure. 30 C57BL/6J-mice were either exposed to mainstream cigarette smoke for 6 hours/day, 31 5 days/week (Smoke Exposed, SE group) or assigned to the control, unexposed group (Con 32 group). SE Group mice were exposed for 8, 16, 24 and 32 weeks to smoke and unexposed 33 Con mice were used as age matched controls. 
Introduction 58
Tobacco smoking is one of the most potent and prevalent addictive habits. It is known that 59 smoking affects multiple organ systems resulting in numerous so-called tobacco-related 60 diseases like chronic obstructive pulmonary disease (COPD). While the effects of cigarette 61 smoke on the respiratory tract are well established, it is becoming more evident that smoking 62 has an important extrapulmonary toxicity. In this regard, numerous studies have 63 demonstrated several extrapulmonary effects of smoking including systemic inflammation 64 and muscle dysfunction. These extrapulmonary effects are particularly pronounced for long 65 time cigarette smoking (LTCS) which leads to a high prevalence of COPD (15,16,64). The 66 so-called systemic effects of LTCS and COPD have been recognized as being also clinically 67 relevant. In fact, it is likely that important clinical outcomes, including mortality or health 68 status, eventually result from the interplay between the intrapulmonary and extrapulmonary 69
effects of LTCS (44).A common systemic effect of LTCS is a decreased exercise capacity. 70
This functional decline was thought to be primarily caused by airway obstruction resulting in 71 increased work of breathing during activity. However, over longer periods there are several 72 other systemic abnormalities which might contribute to functional declines in LTCS or COPD 73 patients (49). Central extrapulmonary effects of smoking are changes in the cellular and 74
humoral inflammatory status (21). Regarding circulating inflammatory cells it was shown that 75
the hematopoietic system is stimulated resulting in an increased release of leukocytes and 76 platelets into the circulation (30). In addition to neutrophils and macrophages it was also 77 demonstrated that T cells, which include both CD4 + and CD8 + cells, were activated and were 78 present in the alveolar walls in emphysema during COPD development (42). The systemic 79 inflammatory status in smokers and COPD patients is also characterized by an increased 80 level of several inflammatory cytokines such as tumor necrosis factor (TNF)-α and C-reactive 81 protein (CRP) (60). However, inflammation affects several other tissues including skeletal 82 muscle (1, 4) . Primarily two types of muscle abnormality were observed in muscles of patients 83 with moderate and severe COPD (6). On the one hand, atrophy occurs in the anaerobic type-84
IIx fibres, leading to a loss of muscle strength. On the other hand COPD patients suffer from 85 the depletion of aerobic type-I fibres and a reduction in mitochondria and oxidative enzymes 86 within both type-I and -IIa fibres, resulting in decreased muscle endurance (20, 23, 27) .The 87 mechanisms of muscle wasting in COPD are intensively discussed. It is assumed that both a 88 reduction of activities as well as the inflammatory status induces skeletal muscle 89 abnormalities (27, 28, 60) . In addition, a large number of oxidants contained in cigarette 90 smoke may also exert direct deleterious effects on skeletal muscles (6). 91
Recently, Seimetz et al. (53) established a mouse model of smoke exposure demonstrating 92 that 8 months of smoke exposure induced pulmonary hypertension and emphysema and 93 right heart hypertrophy. However, functional capacity, systemic inflammation and effects of 94 muscle tissue were not elucidated. 95
The main objective of this study was to investigate the time dependent effects of cigarette 96 smoke exposure on exercise capacity, markers of systemic inflammation and skeletal muscle 97 tissue in a mouse model. Therefore, mice were exposed to cigarette smoke using a whole 98 body cigarette smoke exposure system. We hypothesized that cigarette smoke exposure 99 reduces maximum oxygen consumption, increases markers of systemic inflammation and 100 affects skeletal muscle composition in favor of loss of oxidative fibers and atrophy. Cell isolation procedure and analysis of inflammatory surface markers 157
At least 4 days after the last exercise bout, mice were anaesthesized by isoflurane and 158 sacrified by cervical dyslocation. Blood was collected by cardiac puncture. In order to 159 investigate systemic inflammatory status, lymphocytes were isolated by density gradient 160 centrifugation. Briefly, 100 µl of whole blood anticoagulated with EDTA was layered upon a 1 161 ml of Percoll (Nycomed, Oslo, Norway) and centrifuged at 400g for 20 min at room 162 temperature. After centrifugation the lymphocyte bandwas removed and cells were 163 repeatedly washed. Cell suspensions were incubated with monoclonal antibodies anti-CD3, 164
anti-CD4, anti-CD8 (FITC-conjugated, ImmunoTools, Friesoythe, Germany),anti-CD62 anti-165 CD54/ICAM, anti-CD106/VCAM (PE conjugated, Beckman Coulter, Krefeld, Germany) and 166
analyzed by Flow cytometry (EPICS XL Flow Cytometer, Beckman Coulter, Krefeld, 167
Germany). 168
Cytokine analysis 169 Serum was tested for apolipoprotein A-I (Apo A-I), CD40 (CD40), CD40 Ligand (CD40-L), 170 CRP, endothelin-1 (ET-1), eotaxin, epidermal growth factor mouse (EGF Mouse), factor VII, 171 fibrinogen, fibroblast growth factor 9 (FGF-9), fibroblast frowth factor basic (FGF-basic), 172 granulocyte ghemotactic protein-2 mouse (GCP-2 Mouse), granulocyte-macrophage colony-173 stimulating factor (GM-CSF), growth-regulated alpha protein (KC/GRO), haptoglobin, 174 immunoglobulin A (IgA), interferon γ (IFN-γ), interferon γ-induced protein 10 (IP-10), 175 interleukin-1 alpha (IL-1 alpha), interleukin-1 β (IL-1 β), interleukin-10 (IL-10), interleukin-11 176 (IL-11), interleukin-12 subunit p70 (IL-12p70)
, interleukin-17A (IL-17A), interleukin-18 177 (IL-18), interleukin-2 (IL-2), interleukin-3 (IL-3), interleukin-4 (IL-4), interleukin-5 (IL-178 5),interleukin-6 (IL-6), interleukin-7 (IL-7), leukemia inhibitory factor (LIF), lymphotactin, 179 macrophage colony-stimulating factor-1 (M-CSF-1), macrophage inflammatory protein-1 180 alpha (MIP-1 α), macrophage inflammatory protein-1 β (MIP-1 β ), macrophage inflammatory 181 protein-1 γ (MIP-1 γ), macrophage inflammatory protein-2 (MIP-2), macrophage inflammatory 182 protein-3 β (MIP-3 β), macrophage-derived chemokine (MDC), matrix metalloproteinase-9 183 (MMP-9), monocyte chemotactic protein 1 (MCP-1), monocyte chemotactic protein 3 (MCP- adjusted with HCl to pH 4.6. After washing, the sections were incubated for 30 min at 37°C in 205 substrate solution (2.7 mM ATP, 100 mM glycin, 54 mM CaCl 2 , 100 mM NaCl, pH adjusted to 206 9.6). After incubations in 11 mM CaCl 2 and 2% CoCl 2 , a black insoluble product was 207 developed in 1% ammonium sulfide for 50 s. As a result type 1 fibers stained darkly, while 208 type II fibers were stained light grey. After washing with distilled water, the sections were 209 analyzed by light microscopy (Leica DMI 6000B, Leica Microsystems, Wetzlar Germany). In 210 order to calculate percentages of the type I and type II fibers and measure muscle fiber 211 cross-sectional area, Leica Application Suite software and Leica QWin software were used 212 (Leica Microsystems, Wetzlar Germany). 213
Microarray analysis 214
A total of 20 RNA samples from 20 different mice (n=5/time point) were subjected to 10 dual-215 color hybridizations. Purified total RNA (1 µg, each) was amplified and Cy-labeled using the 216 dual-color LIRAK kit (Agilent) following the kit instructions. The samples were labeled with 217 either Cy3 or Cy5 to match a balanced dye-swap design for each group. Cy3-and Cy5-218 labeled RNAs were hybridized overnight to 4x44K 60mer oligonucleotide spotted microarray 219 slides (Mouse Whole Genome 4x44K; Agilent Technologies, design ID 014868). 220
Hybridization and subsequent washing and drying of the slides were performed following the 221
Agilent hybridization protocol. 222
The dried slides were scanned using the GenePix 4100A scanner ( 
Statistical analysis 235
Data are means ± SEM, unless indicated otherwise in the figure legends. Differences 236 between the points of time were performed by analysis of variance followed by Bonferroni's 237
Multiple Comparison Test. For comparison of two groups, a Student's t test was performed. 238
Pearson's correlation analysis was used to identify any significant relationship. We 239 
Body mass and exercise capacity 255
Both groups, Con and SE mice, started with a similar average body mass and showed 256 increase of body mass with time. However, mice of the SE group exhibited a statistically 257 significant lower body mass compared to the corresponding controls at all time points 258 (p<0.05, Table 1 ). 259
We further tested the exercise capacity of the mice after 8, 16, 24 and 32 weeks. As depicted 260
in Figure 1 , smoke-exposed mice showed a significant reduced VO 2max compared to the age-261 matched controls at the 16, 24 and 32 week time points. A remarkable attenuation of gain in 262
Vmax compared with respective controls was observed at 24 weeks (p<0.05, Figure 1) . 263
Inflammatory markers on lymphocytes 264
In order to evaluate inflammatory changes on cellular level, surface markers on lymphocytes 265 were analyzed. A statistically significant increase of CD62 expression was found after 24 and 266 32 weeks in mice of the SE group compared to age matched controls (p<0.05, Figure 2A) . 267
Similarly, an increase of ICAM expression and VCAM expression was found in SE mice. 268
Thereby, ICAM expression increased early on CD4 and CD8 cells (16 weeks), while an 269 increase of VCAM was found at 24 weeks of SE (p<0.05, Figure 2B and C). On CD8 cells, a 270 late increase of both markers was found (week 32) (p<0.05, Figure 2D and E). 
Muscle weight, fiber type and cross-sectional area 286
While muscle weight of the Con group increased slightly over time, a smaller increase or 287 decrease was found after 24 and 32 weeks in weight of m. rectus femoris, m. soleus, and m. 288 gastrocnemius of the SE group (p<0.05, Table 2 ). In addition to muscle weight, changes in 289 muscle fiber type and muscle fiber cross-sectional area were analyzed selectively for type I 290 and type II fibers. Here a time dependent decrease of oxidative type-I fibers in m. rectus 291 femoris, m. soleus, and m. gastrocnemius was found (p<0.05, Figure 4A ). In parallel, SE 292 mice showed a decrease of muscle fiber cross-sectional area in both fiber types (type I and 293 type II fibers) (p<0.05, Figure 4B ). Type II fiber area decreased early in the rectus femoris 294 muscle (16 weeks). In contrast, a statistically significant decrease of area of muscle fibers in 295 type I fibers was not observed until week 32 (p<0.05, Figure 4B) . 296
Microarray analysis of muscle tissue 297
Microarray analysis revealed effects of smoke exposure on several muscular signaling 298 pathways. The pathways were selected by controlling of the false-discovery rate to 5%. 299
While only the PPAR pathway was clearly affected at 8 weeks, we could identify effects on 300 several pathways at 16 weeks of SE. In particular, the identified pathways were related to 301 diseases (Parkinson's disease, Alzheimer's disease, Huntington disease), general metabolic 302 processes (oxidative phosphorylation, nitrogen metabolism, fatty acid metabolism, citrate 303 cycle) as well as to the protein/amine acid metabolism and degradation (alanine, aspartate 304 and glutamate metabolism, β -alanine metabolism, glutathione metabolism, valine, leucine 305 and isoleucine degradation, cysteine and methionine metabolism, arginine and proline 306 metabolism). Furthermore, the pH regulative proximal tubule bicarbonate reclamation 307 pathway was regulated and PPAR signaling pathway was still upregulated. While no pathway 308 regulation could be identified at 24 weeks, at 32 weeks the only altered pathway was 309 olfactory transduction (Table 3) . 310
Analysis of single genes revealed a down-regulation of several genes known to be related to 311 increasing percentage of type I fibers. This down-regulation was observed at 16 and 24 312 weeks of smoke exposure (e.g. Pdk4: --1.00 (-1.1, 0.53) (24 weeks), Ppargc1b:-0.87 (-313 1.33,-0.41) (16 weeks). We further found an up-regulation of several genes which are 314 We further analyzed the correlation between the expression of selected genes in muscle and 325 cytokines in plasma at all time points. Here it was found that the expression of several 326 inflammation related genes, like CCL-2, CCL-7, CCL-9 or CSF-1, which exhibit chemotactic 327 activities on leukocytes, correlated with the level of respective plasma cytokines over time 328 (p<0.05) ( Table 4) . factors which comprise lung diffusion, stroke volume, blood volume, capillary density of the 367 skeletal muscle and muscle oxygen extraction (7). Therefore, it has been speculated that 368 also the loss of type I oxidative muscle fibers supported the decline of VO 2max . However, 369 several other factors including pulmonary hypertension and changes in cardiac output are 370 known to accelerate the stepwise decline of exercise capacity in COPD patients (30). 371
In order to investigate the time course of systemic inflammation, expression of adhesion 372 molecules on lymphocytes was analyzed. It was previously demonstrated that ICAM-1, 373 VCAM-1and CD62L were associated with air pollution, the occurrence of asthma, and COPD 374 (2). However, in these studies, molecules were found increased in several forms such as 375 soluble in serum (2), expressed in pulmonary fibroblasts (65), and expressed on the 376 endothelium (31). We have demonstrated that these molecules also showed increased 377 expression on the lymphocyte cell surface in response to smoke exposure, indicating an 378 increased activation state of these cells. Upregulation of these surface proteins might induce 379 lymphocyte recruitment through the bronchial circulation. It is likely that the biphasic 380 regulation of some of these markers reflect a status of acute and chronic inflammation (14) . showed a biphasic infiltration pattern in the lungs of smoke-exposed mice. Therefore, it is 387 assumed that ICAM-1 might mediate migration into lung tissue. Possibly, a first increase of 388 cellular infiltration is followed by an anti-inflammatory counter-regulation, which might 389 account for the decreased expression observed during the time course. Furthermore, it can 390 be speculated that an interim decrease of inflammation might be the result of a temporary 391 habituation to the smoke exposure. patients (17). It was found that COPD patients displaying cachexia can be distinguished from 461 patients not displaying cachexia by increased serum levels of aspartate and arginine levels. 462 Therefore, it is suggested that the up-regulation of some aminoacid metabolism pathways 463 might be the result of tissue degradation. An upregulation of arginine-proline metabolism can 464 be classified as a general feature of cachectic patients because it was observed in COPD 465 subjects as well as in cachectic cancer patients (17,44). Recently, decreased glutamate and 466 reduced glutathione levels were reported in the quadriceps femoris of patients with COPD. 467 Thereby, glutamate is an important precursor for the first and rate-limiting step in the 468 synthesis of reduced glutathione, one of the most important antioxidants in muscle (5). 469
Reduced muscle glutathione levels often result in an antioxidant/oxidant imbalance, 470 increasing the susceptibility of the muscle to oxidative stress and cell injury (18). However, 471 current concepts assume that oxidative stress plays a relevant role in the generation of 472 skeletal muscle abnormalities in COPD (5). 473
In summary, the present data give an overview about the time course of some important 474 extrapulmonary effects of LTCS and COPD pathogenesis. A decrease of endurance capacity 475 and systemic inflammation seem to be early events of smoke exposure which progress 476 during the status of chronic inflammation. In parallel, several muscular signaling pathways 477 are regulated which might induce protein degradation resulting in atrophy and loss of 478 oxidative fibers. Of course, since this study is primarily descriptive, the causal relationships 479 between the different changes must be further explored. Tab. 3: Microarray analysis of the effect of smoke exposure on several muscular signaling pathways. The pathways were selected by controlling of the false-discovery rate at 5%. Tab. 4: Selected key genes in muscle and cytokines in plasma which are regulated in muscle tissue and plasma (mean log 2 fold-changes after 8, 16, 24 and 32 weeks smoke exposure with 95% confidence intervals in brackets, and log 2 expression as average over all time points). 
